Conjugate comprising oxyntomodulin and an immunoglobulin fragment, and use thereof Grant US-11872283-B2 United States of America 16 Jan 2024
GLP-1R/GCGR dual target agonist polypeptide for treatment of fatty liver diseases… Grant US-11197914-B2 United States of America 14 Dec 2021
Liquid formulation of long-lasting protein conjugate comprising the oxyntomodulin and an… Grant US-11071785-B2 United States of America 27 Jul 2021
EFINOPEGDUTIDE FOR USE IN THE TREATMENT OF SEVERE NON-DIABETIC OBESITY Application WO-2020128967-A3 World Intellectual Property Organisation (WIPO) 30 Jul 2020